Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131872 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts
A Phase 2 study, sponsored by LeMaitre Vascular.
- Terminated
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
NCT00131872 is a Phase 2 study that was terminated before completion, run by LeMaitre Vascular. The registered enrollment target is 172 participants.
The verdict
NCT00131872, a Phase 2 study, was terminated before completion, sponsored by LeMaitre Vascular.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the substantial equivalence of Expedial and ePTFE grafts for effectiveness in maintaining primary or assisted primary patency.
Interventions
- DEVICE Expedial Vascular Access Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2004-03 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00131872
The ClinicalTrials.gov registry entry for NCT00131872 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LeMaitre Vascular, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Expedial Vascular Access Graft is the first listed.
NCT00131872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00131872 about?
NCT00131872 is a clinical study titled "Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts". The purpose of this study is to establish the substantial equivalence of Expedial and ePTFE grafts for effectiveness in maintaining primary or assisted primary patency.
What is the current status of trial NCT00131872?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2004-03. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00131872?
The interventions under investigation include: Expedial Vascular Access Graft (DEVICE).
Who is sponsoring clinical trial NCT00131872?
This trial is sponsored by LeMaitre Vascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.